OCT angiography 2023 update: focus on diabetic retinopathy

Acta Diabetol. 2024 May;61(5):533-541. doi: 10.1007/s00592-024-02238-9. Epub 2024 Feb 20.

Abstract

Optical coherence tomography angiography (OCTA) has become part of the clinical practice and its growing applications are in continuous development. Coherently with the growing concern about the human and economic cost of diabetes, diabetic retinopathy (DR) was the most popular topic for OCTA studies in the past year. The analysis of the literature reveals that applications of OCTA in DR are in continuous growth. In particular, ultrawide field (UWF) OCTA and artificial intelligence (AI) based on OCTA images are affirming as the new frontiers of scientific research in the field. Diagnostic accuracy of AI methods based on OCTA is equal or superior to the one based on OCT methods and also bears potential to detect systemic associations. UWF OCTA is noninvasive method that is reaching similar accuracy of FA in detection of neovascularization and intraretinal microvascular abnormalities (IRMAs) and has allowed better characterization of microvascular peripherical changes in DR. Lastly, deep capillary plexus (DCP) characteristics seem to play a pivotal role in the development of diabetic macular edema (DME) and refinement of biomarkers for different phenotypes of DME and diabetic macular ischemia (DMI) is currently on its way.

Keywords: Artificial intelligence; Diabetic macular edema; Diabetic macular ischemia; Diabetic retinopathy; OCTA; UWF.

Publication types

  • Review

MeSH terms

  • Angiography / methods
  • Artificial Intelligence
  • Diabetic Retinopathy* / diagnosis
  • Diabetic Retinopathy* / diagnostic imaging
  • Fluorescein Angiography / methods
  • Humans
  • Retinal Vessels / diagnostic imaging
  • Retinal Vessels / pathology
  • Tomography, Optical Coherence* / methods